Abou-Alfa GK - Search Results

1

Long term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapy.

Cowzer D, Soares K, Walch H, Gönen M, Boucher TM, Do RKG, Harding JJ, Varghese AM, Reidy-Lagunes D, Saltz L, Connell LC, Abou-Alfa GK, Wei AC, Schultz N, Kingham TP, D'Angelica MI, Drebin JA, Balachandran V, Sanchez-Vega F, Kemeny NE, Jarnagin WR, Cercek A. Cowzer D, et al. Among authors: abou alfa gk. J Natl Cancer Inst. 2024 Sep 27:djae202. doi: 10.1093/jnci/djae202. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39331613

2

Outcome of patients with fibrolamellar hepatocellular carcinoma.

Stipa F, Yoon SS, Liau KH, Fong Y, Jarnagin WR, D'Angelica M, Abou-Alfa G, Blumgart LH, DeMatteo RP. Stipa F, et al. Cancer. 2006 Mar 15;106(6):1331-8. doi: 10.1002/cncr.21703. Cancer. 2006. PMID: 16475212 Free article.

3

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma.

Abou-Alfa GK, Schwartz L, Ricci S, Amadori D, Santoro A, Figer A, De Greve J, Douillard JY, Lathia C, Schwartz B, Taylor I, Moscovici M, Saltz LB. Abou-Alfa GK, et al. J Clin Oncol. 2006 Sep 10;24(26):4293-300. doi: 10.1200/JCO.2005.01.3441. Epub 2006 Aug 14. J Clin Oncol. 2006. PMID: 16908937 Clinical Trial.

4

Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.

Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, Kemeny N, O'Reilly E, Abou-Alfa GK, Shimada H, Blumgart LH, Jarnagin WR. Endo I, et al. Ann Surg. 2008 Jul;248(1):84-96. doi: 10.1097/SLA.0b013e318176c4d3. Ann Surg. 2008. PMID: 18580211

5

Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).

Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, D'Angelica M, Dematteo RP, Blumgart LH, O'Reilly EM. Duffy A, et al. J Surg Oncol. 2008 Dec 1;98(7):485-9. doi: 10.1002/jso.21141. J Surg Oncol. 2008. PMID: 18802958

6

Current management of advanced hepatocellular carcinoma.

Abou-Alfa GK, Huitzil-Melendez FD, O'Reilly EM, Saltz LB. Abou-Alfa GK, et al. Gastrointest Cancer Res. 2008 Mar;2(2):64-70. Gastrointest Cancer Res. 2008. PMID: 19259298 Free PMC article.

7

Advanced hepatocellular carcinoma: which staging systems best predict prognosis?

Huitzil-Melendez FD, Capanu M, O'Reilly EM, Duffy A, Gansukh B, Saltz LL, Abou-Alfa GK. Huitzil-Melendez FD, et al. J Clin Oncol. 2010 Jun 10;28(17):2889-95. doi: 10.1200/JCO.2009.25.9895. Epub 2010 May 10. J Clin Oncol. 2010. PMID: 20458042 Free PMC article.

8

Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.

Abou-Alfa GK, Johnson P, Knox JJ, Capanu M, Davidenko I, Lacava J, Leung T, Gansukh B, Saltz LB. Abou-Alfa GK, et al. JAMA. 2010 Nov 17;304(19):2154-60. doi: 10.1001/jama.2010.1672. JAMA. 2010. PMID: 21081728 Clinical Trial.

9

Doxorubicin and sorafenib for treatment of advanced hepatocellular cancer.

Abou-Alfa GK, Saltz LB. Abou-Alfa GK, et al. Gastroenterology. 2011 Sep;141(3):e19-20; author reply e20-1. doi: 10.1053/j.gastro.2011.04.063. Epub 2011 Jul 24. Gastroenterology. 2011. PMID: 21794834 No abstract available.

10

A Nonrandomized, Phase II Study of Sequential Irinotecan and Flavopiridol in Patients With Advanced Hepatocellular Carcinoma.

Ang C, O'Reilly EM, Carvajal RD, Capanu M, Gonen M, Doyle L, Ghossein R, Schwartz L, Jacobs G, Ma J, Schwartz GK, Abou-Alfa GK. Ang C, et al. Gastrointest Cancer Res. 2012 Nov;5(6):185-9. Gastrointest Cancer Res. 2012. PMID: 23293699 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters